01/17/2020 12:00 AM EST
Source: National Institutes of Health (NIH). Published: 1/17/2020. This web page provides information, recordings, and documents from a meeting held on January 16-17, 2020, for HEAL (Helping to End Addiction Long-term) investigators. HEAL is an aggressive, trans-agency effort to speed scientific solutions to stem the national opioid public health crisis. Goals of the meeting included establishing the HEAL investigator network through streamlined communications and the shared expertise of HEAL researchers; increasing awareness of the geographic, thematic, and programmatic scope of HEAL; and exploring commonalities and enhancing individual programs to optimize the successes of HEAL. (Video or Multimedia)
01/16/2020 12:00 AM EST
Source: AMR Industry Alliance. Published: 1/16/2020. The data and case studies collected and published in this 2020 progress report provide insights into the practical steps the Alliance’s members are taking to curb the spread of antimicrobial resistance in the areas of research and science, access, and appropriate use, as well as steps to reduce the environmental impact of manufacturing. The report outlines a forward-looking agenda listing the next steps which the Alliance is committed to take. (PDF)
01/02/2020 12:00 AM EST
Source: Committee for Tactical Emergency Casualty Care (C-TECC). Published: 1/2/2020. This five-page document provides 11 tactical emergency casualty care actions for active bystanders to take, including for severe bleeding, airway management, hypothermia, burns, pain control, and shock. It also provides definitions for related terms. (PDF)
12/13/2019 12:00 AM EST
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 12/13/2019. This web page provides information and documents related to the Health and Human Services (HHS) ASPR Incident Response Framework, which represents a vital step forward in strengthening and integrating the response to all-hazards incidents and special events preparedness, and bringing HHS's approach into alignment with the National Incident Management System (NIMS)/Incident Command System (ICS) doctrine at the federal level. (Text)
11/01/2019 12:00 AM EDT
Source: World Health Organization (WHO). Published: 11/2019. This web page provides information, data visualization, and results from the World Health Organization (WHO)'s review of preclinical antibacterial products in the pipeline worldwide. It captures data on 252 antibacterial agents in development, targeting the pathogens on the WHO priority pathogens list, Mycobacterium tuberculosis, and Clostridium difficile. (Text)
11/01/2019 12:00 AM EDT
Source: World Health Organization (WHO). Published: 11/2019. This web page provides information and data results from the World Health Organization (WHO) analysis of the pipeline of antibacterial products (antibiotics and biologicals) that were in phase I-III of clinical development (as of September 2019) and which had not, at that date, received market authorization for human use anywhere in the world. The analysis matched the products in development against the WHO priority pathogens list (PPL), Mycobacterium tuberculosis, and Clostridium difficile. (Text)
01/01/2019 12:00 AM EST
Source: World Health Organization (WHO). Published: 2019. This 48-page report is the World Health Organization (WHO)'s third annual review of the clinical antibacterial pipeline to analyze how the pipeline responds to the WHO priority pathogens list. It covers direct-acting small molecules and biological agents that are in development worldwide, and assesses to what extent the pipeline addresses the WHO priority pathogens, Mycobacterium tuberculosis and Clostridioides difficile, and to what extent the antibacterial agents are innovative. It is part of WHO efforts in global research and development priority-setting to contain antimicrobial resistance. (PDF)
01/01/2019 12:00 AM EST
Source: World Health Organization (WHO). Published: 2019. This 20-page document is the World Health Organization (WHO)’s first comprehensive overview of the preclinical antibacterial pipeline to date based on publicly available data on each included project. This report and the respective WHO database capture 252 antibacterial agents in development targeting the pathogens on the WHO priority pathogens list (Annex I), Mycobacterium tuberculosis and Clostridioides difficile. (PDF)
01/01/2019 12:00 AM EST
Source: Natural Hazards Center [University of Colorado at Boulder]. Published: 2019. Using focus groups of emergency agencies and documents (e.g., daily situation reports) as the major data collection method, this study describes secondary and primary infrastructure available for long-term shelter operations in Bay County, Florida, in the aftermath of Hurricane Michael in 2018. It illuminates the emerging relationship between shelters and primary and secondary infrastructure during hurricane recovery, and concludes that those relationships may be utilized to support operation of shelters and overall community recovery. (Text)
.png)
No hay comentarios:
Publicar un comentario